Page 387 - AIDSBK23C
P. 387
Page 387
1111 Halevy A, Brody A. Acquired immunodeficiency syndrome and the Americans with
Disabilities Act: a legal duty to treat. Am J Med. 1994;96:282-291.
1112 Centers for Disease Control. Recommendations for preventing transmission of human
immunodeficiency virus (HIV) and hepatitis B virus (HBV) to patients during exposure-
prone invasive procedures. MMWR. 1991;40(RR-8):1-9.
1113 Phillips KA, Lowe RA, Kahn JG, Lurie P, Avins AL, Ciccarone D. The cost-
effectiveness of HIV testing of physicians and dentists in the United States. JAMA.
1993;271:851-858.
1114 Head KC, Bradley-Springer L, Sklar D. The HIV-infected health care worker: legal,
ethical, and scientific perspectives. J Emerg Med. 1994;12:95-102.
1115 Owens DK, Harris RA, Scott PMcJ, Nease RF Jr. Screening surgeons for HIV infection:
a cost-effectiveness analysis. Ann Intern Med. 1995;122:641-652.
1116 Centers for Disease Control and Prevention. HIPAA Privacy Rule and Public Health:
Guidance from CDC and the U.S. Department of Health and Human Services. MMWR.
2003;52(Sup1):1-24.
1117 Centers for Disease Control and Prevention. Revised guidelines for HIV counseling,
testing, and referral. MMWR. 2001;50(RR-19):1-57.
1118 Kasten MJ. Human immunodeficiency virus: the initial physician-patient encounter.
Mayo Clin Proc. 2002;77:957-962.
1119 Kendrick SR, Kroc KA, Withum D, Rydman RJ, Branson BM, Weinstein RA. Outcomes
of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. J
Acquir Immune Defic Syndr. 2005;38:142-146.
1120 Whyte GS, Savoia HF. The risk of transmitting HCV, HBV, or HIV by blood transfusion
in Victoria. Med J Aust. 1997;166:584-586.
1121 Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence of
major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. JAMA.
2000;284:229-235.
1122 Takei T, Amin NA, Schmid G, Dhingra-Kumar N, Rugg D. Progress in global blood
safety for HIV. J Acquir Immune Defic Syndr. 2009;52(Suppl 2):S127-131.
1123 Centers for Disease Control. Testing for antibodies to HIV type 2 in the United States.
MMWR. 1992;41[RR-12]:1-9.
